TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Walker Marlan D
TherapeuticsMD | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(25.73%),David Rosen(25.73%)
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Rubric Capital Management LP
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Officer ZIEGLER JOSEPH
TherapeuticsMD | 3: Initial statement of beneficial ownership of securities-Officer ZIEGLER JOSEPH
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Thompson Tommy G
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Naughton Gail K
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Collins Cooper C.
TherapeuticsMD | D: Filing D
TherapeuticsMD | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(19.57%),David Rosen(19.57%)
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Rubric Capital Management LP
TherapeuticsMD | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Walker Marlan D
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Walker Marlan D
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Officer Donegan Michael C
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities
TherapeuticsMD | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Rubric Capital Management LP
TherapeuticsMD | 5: Annual statement of changes in beneficial ownership of securities-Chief Executive Officer Walker Marlan D
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities
No Data